The largest database of trusted experimental protocols

Alzet 2006

Manufactured by Durect
Sourced in United States

The Alzet 2006 is a miniature osmotic pump designed for continuous and controlled delivery of substances in laboratory animals. It is a self-contained, implantable device that operates without the need for external connections or programmer. The pump delivers the substance at a pre-determined, consistent rate over an extended period of time.

Automatically generated - may contain errors

Lab products found in correlation

3 protocols using alzet 2006

1

IGF-1 Delivery via Osmotic Minipumps

Check if the same lab product or an alternative is used in the 5 most similar protocols
Osmotic minipumps (ALZET® 2006, DURECT Corporation, Cupertino, CA, USA; pumping rate 0.15 µL/h) were filled and connected to a hook-delivery device (HDD) consisting of a commercially available silicone catheter (ALZET® rat jugular catheter, DURECT Corporation, USA; 0.94 mm OD; 0.51 mm ID) and a small hook-shaped stainless-steel tip (Nordson Optimum® #7018433, Nordson Deutschland GmbH, Erkrath, Germany) with an outer diameter of 0.31 mm [43 (link)]. Pumps for control animals were filled with artificial perilymph (AP; 145 mM NaCl, 2.7 mM KCl, 2.0 mM MgSO₄, 1.2 mM CaCl₂, 5.0 mM HEPES, pH = 7.4 with 0.1% guinea pig serum albumin) [96 (link)]. The pumps of the treatment group were filled with IGF-1 (Recombinant Human IGF-1, #100-11, PeproTech® Germany, Hamburg, Germany) in a concentration of 2 μg/mL diluted in AP. The pumping rate of the osmotic pump results in a release of 0.3 ng IGF-1 per hour. During the priming time of 60 h each pumps’ function was macroscopic controlled by fluid drain out of the catheters’ tip [43 (link)]. After the in vivo experiment, the pumping of the explanted pumps was re-checked the same way.
+ Open protocol
+ Expand
2

ANGII-Induced Hypertension in Rat Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
3-to-5-month male WT and P2rx7−/− rats were anesthetised with 3% isoflurane inhalation in 100% O2, and an osmotic minipump (Alzet 2006, Durect, Cupertino, CA) was implanted subcutaneously using aseptic techniques. ANGII was infused at a rate of 250 ng/kg/min for ~ 6 weeks. Naive age-matched rats were used as controls. Preliminary experiments revealed that ANGII infusion was poorly tolerated by F344 rats, as shown by signs of illness including body weight loss, loss of grooming, reluctance to move, and abnormal posture. Following advice of our veterinary team, blood pressure was not recorded to avoid excessive handling of the animals that may cause stress, and mashed food was provided throughout the entire experiment to facilitate feeding and avoid excessive body weight loss. At the end of ANGII infusion period, rats were culled by CO2 asphyxiation. Bladder urine was collected for urine analyses, and kidney and heart were weighed and processed for histological analyses. Tibia length was measured using a digital calliper.
+ Open protocol
+ Expand
3

Murine Cardiac Ischemia and Angiotensin II

Check if the same lab product or an alternative is used in the 5 most similar protocols
This investigation was authorized by the Institutional Animal Care and Use Committee of Harbin Medical University (IRB3006217). All experimental procedures were executed in compliance with the NIH Guide for the Care and Use of Laboratory Animals. Briefly, the left anterior descending coronary artery (LAD) of eight-week-old male C57BL/6 mice was ligated with 7-0 nylon at 1-2 mm below the left atrium for 28 days. In sham mice, the LAD was passed through with sutures but not ligated. Eventually, echocardiography was used to evaluate cardiac function, and subsequently, serum and heart tissues were stored at -80°C. For AngII infusion mice, alzet osmotic mini-pumps (Alzet 2006; Durect Corporation, California, 0.15 μl/h) infusing AngII (A9525, Sigma-Aldrich Corporation, Missouri, 25 mg/ml) were implanted subcutaneously in the dorsal region. After the pump was submerged for 8 weeks, the Ang II pumps were not replaced, heart was harvested for further experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!